Expression of THBS2 in human PanIN tissue and PDAC tumor tissue

Slides:



Advertisements
Similar presentations
Supplemental Figure 1. Specificity of CCL2 and Fsp1 immunostaining of breast tumor tissues. Sections of invasive ductal carcinoma were incubated with primary.
Advertisements

Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells  Takahisa Fujikawa, Seh-Hoon.
Podocalyxin-Like Protein 1 Expression and Correlation with Clinical Characteristics in Epithelial Serous and Mucinous Ovarian Carcinoma and Tumor-Like.
Genetics and pathology of pancreatic cancer
Fig. 1. TP is highly expressed in myeloma.
Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.
Fig. 4. Primary human metastatic melanomas contain CCL21-expressing LECs, and expression of VEGFC positively correlates with hallmarks of tumor inflammation.
Volume 133, Issue 1, Pages (July 2007)
Fig. 1. Generation of ERY974. Generation of ERY974. (A) Schematic illustration of ERY974 structure and the introduced mutations. The two Fab arms share.
Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.
Transfer of miR-223 during neutrophil-epithelial cell interactions
In vivo function of MeTro sealants using rat incision model of lungs
Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.
Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.
Fig. 2. In vitro profiling of tEV markers on cell line–derived EVs.
Fig. 1 Localized treatment of TNBC cancers kills tumor cells and minimizes the metastatic burden. Localized treatment of TNBC cancers kills tumor cells.
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
Fig. 4. Characterization of human liver seed graft morphology.
Intravenous delivery of reovirus to primary and secondary brain tumors
Fig. 2. GPC3 expression in normal and tumor tissues.
Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.
Fig. 5. Immunohistochemistry of the tumor microenvironment in GBM specimens before and after CART-EGFRvIII infusion. Immunohistochemistry of the tumor.
Expression of CD36 and psap in a TMA of human ovarian cancer patients
Fig. 6. PVSRIPO oncolysate–pulsed DCs generate tumor antigen–specific CTL immunity in vitro. PVSRIPO oncolysate–pulsed DCs generate tumor antigen–specific.
Fig. 4 Expression of cleaved caspase 3, PD-L1, and PD-1 in HGGs after reovirus treatment. Expression of cleaved caspase 3, PD-L1, and PD-1 in HGGs after.
Fig. 5. Vascularization of human liver seed grafts.
Fig. 4. Antitumor efficacy of ERY974 against various cancer types.
Fig. 1. CD31 is present throughout the human renal vasculature.
Dot plots of trisomic versus fetal fractions for cohorts 1 and 2
Immunofluorescence staining of virus-infected human placental explants
Volume 3, Issue 6, Pages (June 2013)
Fig. 4. MATE1 transcription in RCC.
Fig. 5. MasSpec Pen analysis of an HGSC tissue sample with mixed histologic composition. MasSpec Pen analysis of an HGSC tissue sample with mixed histologic.
Fig. 4 Nanocages captured multiple TB-related analytes.
Fig. 5 Hypoxic tumors from obese mice associate with increased production of IL-6 by adipocytes and myeloid cells. Hypoxic tumors from obese mice associate.
Persistence of CAR4 cells is reduced after sustained TCR engagement
Fig. 5 EGFR mutation status of patients with NSCLC, detected by histological examination and ARMS PCR. EGFR mutation status of patients with NSCLC, detected.
Fig. 7. KIF11 informs patient prognosis, and targeting improves survival in a preclinical model. KIF11 informs patient prognosis, and targeting improves.
Fig. 2. Pathways differentially regulated in patients with early Lyme disease and STARI. Pathways differentially regulated in patients with early Lyme.
Fig. 7. Inhibitory mechanisms of C12G6.
Fig. 5 Local gel scaffold for T cell memory response.
IHC staining of various cystic structures
Fig. 1. In vitro binding and neutralization activities of C12G6.
Fig. 7 CSPG4-high GBMs show more microglia than CSPG4-low GBMs and express TNFα. CSPG4-high GBMs show more microglia than CSPG4-low GBMs and express TNFα.
Fig. 1 Undetectable ALK expression in monocytes and macrophages.
Fig. 3 Hepatic HBV envelope RNA and protein expression levels in HBVRplRag−/− mice 7 days (1 week) and 8 to 24 weeks after adoptive transfer with WT or.
Fig. 1 CSPG4 is expressed in GBM specimens and GBM-NS and associated with more aggressive disease. CSPG4 is expressed in GBM specimens and GBM-NS and associated.
Existence of a nuclear NFATc1–STAT3 complex in pancreatic cancer.
Fig. 4. Acute lung injury in miR-223−/y mice.
Fig. 5. Prophylactic and therapeutic efficacy of C12G6 in ferrets.
Fig. 3 CSF1 is expressed in human melanoma.
Fig. 3 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART selectively reverses baseline blocks to splicing, elongation, and.
B cells infiltrate mouse and human pancreatic neoplasia and promote growth of KrasG12D-PDEC in vivo. B cells infiltrate mouse and human pancreatic neoplasia.
Dual‐recombinase fluorescence lineage tracing of EMT in KPF (FSF‐KrasG12D/+;Trp53frt/+;Pdx1‐Flp);αSMA‐Cre;R26Dual mice Dual‐recombinase fluorescence lineage.
NICD1 immunohistochemical staining in normal and tumor tissue.
Correlation of reovirus RNA/protein with proliferating tumor cells
Fig. 5. Rises in RSV PRNT during the surveillance period.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
SIRT1 is downregulated in human gastric cancer (GC).
(A) Sequential subtype (B) Branch-off subtype (C) De novo subtype
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
IL6 mRNA is not detected in metastatic prostate cancer cells.
Expression of XCR1 in normal ovarian surface epithelium and the IOSE and borderline EOC cell lines. Expression of XCR1 in normal ovarian surface epithelium.
Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI Using Revised 2017 International Consensus Guidelines.
Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8 and Stat3+/+:HPV8 mice. Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8.
Tumorigenicity of GR CAFs
NIX loss delays cancer progression in KRAS-driven models of PDAC
Figure 7b. Complications of pancreatitis mimicking a pancreatic tumor
Fig. 3. Association between peak CTL019 expansion and response.
Epithelial and stromal percentage clusterin staining in normal nonadjacent colonic tissue and matched tumor tissue in 202 patients with stage II colorectal.
Presentation transcript:

Fig. 4. Expression of THBS2 in human PanIN tissue and PDAC tumor tissue. Expression of THBS2 in human PanIN tissue and PDAC tumor tissue. (A and B) Representative THBS2 immunohistochemistry analysis of incidental PanIN1/2 tissue derived from the head and neck of a pancreas from a patient with pancreatic periampullary cancer using two different antibodies (Ab). The arrows indicate that PanIN2 tissue stained positive for THBS2; dotted arrows indicate weak or negative staining of PanIN1 tissue. (C to K) THBS2 expression, designated by arrows, was also confirmed in stage II (C to E) and stage III (F to K) PDAC pancreatic cancer tissue arrays. Competitive assays were performed for antibody #2 by preincubating the antibody with a 10-fold excess of antigen peptide (E, H, and K) to confirm target specificity. Brown color indicates THBS2 staining, and blue color indicates hematoxylin nuclear staining. THBS2 was detected in the epithelial cells of noninvasive lesions (PanINs and intraductal papillary mucinous neoplasms) and poorly differentiated PDAC tissue as well as in fibroblasts in invasive PDAC tissue (see table S8 and fig. S6). Jungsun Kim et al., Sci Transl Med 2017;9:eaah5583 Published by AAAS